CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Typ 2-diabetes lower costs of diabetes care with insulin glargine compared to insulin detemir in type 2 diabetes patients treated with a basal-bolus regimen
DOI 10.1055/s-0029-1222039
Bibliografische Angaben
Nachweis in CareLit
Autor:innenRA Bierwirth, T Kohlmann, KH Theobald, R Holle, W Landgraf
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe05/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: Basal insulin analogs are well-established drugs in the treatment of diabetes. Besides clinical aspects the economic impact of such drugs on health care systems is very important. We examined and compared resource utilization and costs of diabetes care in type 2 diabetic (T2D) patients treated in a basal-bolus regimen with either glargine (GLA) or detemir (DET) as basal insulin. Methods: LIVE-COM* was a n…
Zitieren
Zitierempfehlung
RA Bierwirth, T Kohlmann, KH Theobald, R Holle, W Landgraf (2009) Typ 2-diabetes lower costs of diabetes care with insulin glargine compared to insulin detemir in type 2 diabetes patients treated with a basal-bolus regimen. Diabetologie und Stoffwechsel (05). https://doi.org/10.1055/s-0029-1222039
Mit CareLit weiterarbeiten